A 'BOLD' experiment in defining the utility of fMRI in drug development

Neuroimage. 2008 Aug 15;42(2):461-6. doi: 10.1016/j.neuroimage.2008.04.268. Epub 2008 Jun 10.

Authors

David Borsook¹, David Bleakman, Richard Hargreaves, Jaymin Upadhyay, Karl F Schmidt, Lino Becerra

Affiliation

¹ Imaging Consortium for Drug Development, Brain Imaging Center, McLean Hospital, Belmont, USA. dborsook@partners.org

PMID: 18598770
DOI: 10.1016/j.neuroimage.2008.04.268

No abstract available

Publication types

Review

MeSH terms

Brain / drug effects*
Brain / physiopathology*
Brain Diseases / drug therapy*
Brain Diseases / physiopathology*
Clinical Trials as Topic / methods*
Drug Evaluation / methods*
Humans
Magnetic Resonance Imaging / methods*
Neuroprotective Agents / administration & dosage*
United States

Substances

Neuroprotective Agents